Recombinant Human IGF2BP2

• Description:

  IGF2 mRNA-binding protein 2 (IGF2BP2), also known as IMP2, was found to be an HMGA2 target gene during early embryonic development. IGF2BP2 belongs to a family of RNA-binding proteins that contain six characteristics of RNA-binding modules, including two N-terminal RNA recognition motifs (RRM1 and RRM2) and four C-terminal hnRNP K-homology (KH1&KH4) domains. Its homolog, IGF2BP1/IMP1, has been shown to be essential for normal embryonic growth and development.

• Gene Name:

  IGF2BP2

• Gene Aliases:

  Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, IMP-2, Hepatocellular carcinoma autoantigen p62, IGF-II mRNA-binding protein 2, VICKZ family member 2, VICKZ2
  Recombinant Human IGF2BP2 (IGF2BP2)

• Gene ID:

  10644

• Accession Number:

  Q9Y6M1

• Organism:

  Human

• Source:

  CHO cells

• Concentration:

  <1.0 EU/μg of recombinant protein as determined by the LAL method.

• Purity:

  >95% as determined by SDS-PAGE

• Solubility:

  A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.

• Function:

  Not determined

• Molecular Weight:

  60

• Shipping Conditions:

  Ambient Temperature

• Storage Conditions:

  Recombinant IGF2BP2 can be stored in working aliquots at 2° - 8°C for one month, or at -20°C to -70°C for twelve months. Avoid repeated freeze/thaw cycles.

• Appearance:

  Lyophilized Powder

• Formulation:

  Recombinant Human IGF2BP2 is lyophilized from 0.2 μm filtered PBS solution, pH7.2 , 5% Trehalose.

• CAS Number:

  9000-83-3